499770-92-2

Basic information

• Product Name: 1,3-BENZOTHIAZOL-6-YLMETHYLAMINE,97%
• Synonyms: 6-(AMINOMETHYL)BENZOTHIAZOLE;1,3-Benzothiazol-6-ylmethylamine;1,3-BENZOTHIAZOL-6-YLMETHYLAMINE,97%;6-Benzothiazolemethanamine(9CI);6-Benzothiazolemethanamine;benzo[d]thiazol-6-ylmethanamine
• CAS NO: 499770-92-2
• Molecular Formula: C8H8N2S
• Molecular Weight: 164.22752
• Product Categories: BENZOTHIAZOLE
• Mol File: 499770-92-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 310.655 °C at 760 mmHg
• Flash Point: 141.68 °C
• Appearance: /
• Density: 1.301 g/cm³
• PKA: 8.60±0.40(Predicted)
• CAS DataBase Reference: 1,3-BENZOTHIAZOL-6-YLMETHYLAMINE,97%(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-BENZOTHIAZOL-6-YLMETHYLAMINE,97%(499770-92-2)
• EPA Substance Registry System: 1,3-BENZOTHIAZOL-6-YLMETHYLAMINE,97%(499770-92-2)

Safety Data

• Hazard Codes: C:Corrosive
• Statements: R34:Causes burns.
• Safety Statements: S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S36/37/39:Wear suitabl
• Hazardous Substances Data: 499770-92-2(Hazardous Substances Data)

Usage

General Description

1,3-BENZOTHIAZOL-6-YLMETHYLAMINE,97% is a chemical compound with a purity of 97%. It is an organic compound with the molecular formula C8H8N2S and a molecular weight of 164.23 g/mol. 1,3-BENZOTHIAZOL-6-YLMETHYLAMINE,97% is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also a common reagent in organic chemistry research and is known for its versatile applications in various chemical reactions. The 97% purity level ensures that it is suitable for use in high-quality research and manufacturing processes.

Upstream product

• 1459730-57-4 tert-butyl (benzo[d]thiazol-6-ylmethyl)carbamate 
• 98589-45-8 benzothiazole-6-acetic acid 

Relevant articles and documents

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN, ETC

The present invention provides compounds useful as c-Met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of c-Met kinase mediated disease or disorders with them.

CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR

Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.

NOVEL JNK INHIBITORS

Disclosed are substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines and imidazo[1,2-d]triazines compounds of the formula: (1.0) Also disclosed are methods for treating JNK1 and ERK mediated diseases using the compounds of formula 1.0.